Filing Details
- Accession Number:
- 0001209191-15-059464
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-07-06 16:11:05
- Reporting Period:
- 2015-07-02
- Filing Date:
- 2015-07-06
- Accepted Time:
- 2015-07-06 16:11:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1601797 | Eric Sullivan | C/O Bluebird Bio, Inc. 150 Second Street Cambridge MA 02141 | Principal Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-07-02 | 250 | $20.70 | 4,466 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-07-02 | 166 | $24.47 | 4,632 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-07-02 | 416 | $163.47 | 4,216 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (right to buy) | Disposition | 2015-07-02 | 250 | $0.00 | 250 | $20.70 |
| Common Stock | Stock Option (right to buy) | Disposition | 2015-07-02 | 166 | $0.00 | 166 | $24.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,000 | 2023-12-02 | No | 4 | M | Direct | |
| 5,004 | 2024-03-03 | No | 4 | M | Direct |
Footnotes
- The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 5, 2015.
- The range in prices for the transaction reported on this line was $163.1700 to $163.7900. The average weighted price was $163.4679. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Includes 316 shares acquired under the bluebird bio employee stock purchase plan on January 31, 2015 and 3900 restricted stock units for common stock granted on July 16, 2014 originally reported on the Form 4 filed on July 18, 2014.
- This option vests over a four-year period, at a rate of twenty-five percent(25%) on November 11, 2014 and in 36 equal monthly installments thereafter.
- This option vests over a four-year period, at a rate of twenty-five percent(25%) on January 1, 2015 and in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
